ZyGEM NZ CSO, David Saul, PhD, Leads Partnership to Advance Point-of-Care Diagnostic Screening

Concept of the ZyGEM integrated extraction-qPCR device currently in early development.

Led by ZyGEM NZ CSO, Dr. David Saul, ZyGEM scientists and engineers have partnered with scientists at the University of Otago to design a hand-held analytical tool for on-the-spot diagnostic screening. Awarded nearly $6 million in funding from the New Zealand Ministry of Business, Innovation and Employment Endeavour Fund, the collaboration will develop nucleic extraction capabilities combined with solid-state qPCR. The platform will purify samples, detect the diagnostic marker and report the result in under 15 minutes, allowing frontline workers to quickly determine results at the point-of-care.

This portable screening device has the potential to serve a critical role in addressing world health and environmental challenges such as contaminated water and infectious diseases. The initial model is expected to be available in 2020.

Read the University of Otago, Department of Anatomy, release.


Sign up for occasional product updates and news from MicroGEM International